Targeting Fibrosis
Fibrosis is the pathological overaccumulation of excess connective tissue as a result of imbalances during the body’s healing processes [...]
Fibrosis is the pathological overaccumulation of excess connective tissue as a result of imbalances during the body’s healing processes [...]
In evaluating potential therapeutic candidates, it is crucial to understand early on in the discovery process if the candidates [...]
At Visikol, our core objective is to help service Clients and product Customers to transform their tissues into quantitative [...]
This year’s College of American Pathologists annual meeting will take place in Orlando, Florida from September 21st to the [...]
Make sure to register for Thermo Fisher’s 24 days of stem cells starting on October 1st. Each week during [...]
Over the last few years, the development of immuno-oncology therapeutics has been on the rise with many leading pharmaceutical [...]
Visikol original spun out of Rutgers University and is now a leading contract research organization in the fields of [...]
This year, BMS will be hosting its 44th annual BMSIARC conference at the Crowne Plaza Princeton Conference Center from [...]
At Visikol, we are dedicated to not only providing our Clients with best-in-class drug discovery services but also continuing [...]
Breast cancer is one of the most commonly diagnosed cancers among American women, and while early detection and intervention [...]